Loading...
Uploaded by ndtvprofit on Jun 3, 2010
The two year old battle to take control of Israeli generic drug firm Taro Pharma has taken a new turn as the suitor Mumbai-based pharmaceutical major Sun Pharmaceuticals gets an offer to sell its holding in Taro at a premium price of $15 per share.
News & Politics
Standard YouTube License
Load more suggestions
All Comments